top of page

ADDITIONAL SERVICES

  • Develop Medical Strategy and Integrated Medical Affairs Plans in alignment with overarching band strategy 

  • Integrate and leverage payer insights to become a strategic partner to Market Access

  • Data generation support:

       o  Phase IIIb & IV

       o  IIS/IITs

       o  RWE

  • Secondary data generation (ex: subgroup, post hoc, meta-analysis)

  • Data dissemination & HCP education:

       o Create Publications Strategic plan

       o Create Medical education Strategic plan 

       o Develop Physicians and Healthcare providers focused training programs to optimize product use and treatment success.

       o Congress planning and execution

  • Design strategic approach to KOL identification and engagement

  • Develop REMS (Risk Evaluation and Mitigation strategies)

  • Organizational Effectiveness:

       o Establish/support Medical strategy groups within medical affairs teams

       o Enhance medical affairs effectiveness by compliantly improving cross-functional alignment within the overall company’s/franchises’ business objectives 

       o MSLs support

       o Define scope/approach and KPIs to help demonstrate Medical Affairs team’s value in a compliant manner

       o Develop training / on-boarding plan for “New to Industry” MDs to help them integrate well and deliver value to the organization while being engaged and motivatedWith warm regards,

MEDICAL AFFAIRS

  • Establish/Support of strategy groups within R&D teams

  • Develop of short-, mid- and long-term Disease Area strategic plans and prioritization tools to drive focused R&D and Business development investments into compounds with the highest potential of success through development and on market

  • Strategic development approach to true focus on the patient needs and development of the packaged offerings beyond just treatment (Beyond the pill)

  • Develop target product profiles (TPPs), minimally acceptable product profiles (MAPPs) and optimal product profiles (OPPs) based on a deep understanding of:

       o   Key future market drivers & trends

Existing science

       o   Evolving market access environment

       o   Validated outlook of future unmet  needs

  • Enhance R&D effectiveness by compliantly improving cross-functional effectiveness within the overall company’s/franchises’ business objectives 

  • Strategic approach to clinical trial planning and design to ensure that phase III data supports not only regulatory approval but also maximizes commercial potential at launch

  • Clinical development teams support with programs execution from strategic decisions to implementation/day-to-day management needs.

  • Organizational realignment/resource optimization

R&D/CLINICAL DEVELOPMENT

  • Evaluation of commercial potential of your products in preparation for partnership discussions with potential partners/investors

  • Portfolio prioritization with the goal of selecting compounds or indications with highest medical value and commercial potential

  • Develop strategic roadmap and launch plan to guide clinical development plan/milestones and endpoints

  • Develop TPPs, MAPPs and OPP based on a deep understanding of:

         o   Key future market drivers & trends

         o   Existing science

         o   Evolving market access environment

         o   Validated outlook of future unmet needs

  • Support most critical strategic, clinical and medical activities to accomplish your next development goals /milestones

  • Support efforts to find optimal pharma partners or advance your product through internal development with available resources

BIOTECH

  • Evaluation of commercial potential of your products/research strategies

  • Develop presentations to potential partners/investors & support team preparations for such interactions

  • Support efforts to find optimal pharma partners/investors or advance your product through internal development with available resources

ACADEMIA

bottom of page